Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL201747 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
glutaminyl-peptide cyclotransferase/Glutaminyl-peptide cyclotransferase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4508] [GtoPdb: 2411] [UniProtKB: Q16769] | ||||||||
GtoPdb | - | - | 7.22 | pKi | 60 | nM | Ki | J Med Chem (2006) 49: 664-77 [PMID:16420052] |
ChEMBL | Inhibitory activity against human glutaminyl cyclase | B | 7.22 | pKi | 60 | nM | Ki | J Med Chem (2006) 49: 664-677 [PMID:16420052] |
ChEMBL | Inhibition of human glutaminyl cyclase expressed in Pichia pastoris by pGAP coupled enzyme assay | B | 7.22 | pKi | 60 | nM | Ki | J Med Chem (2009) 52: 7069-7080 [PMID:19863057] |
ChEMBL | Inhibition of human recombinant glutaminyl cyclase expressed in Escherichia coli using H-Gln-Gln-H substrate measured for 15 mins by spectrophotometry | B | 5.28 | pIC50 | 5300 | nM | IC50 | Bioorg Med Chem (2016) 24: 2280-2286 [PMID:27061673] |
ChEMBL | Inhibition of recombinant human QC using H-Gln-AMC hydrobromide as fluorogenic substrate incubated for 6 hrs by fluorometric microplate reader analysis | B | 7.54 | pIC50 | 29 | nM | IC50 | ACS Med Chem Lett (2022) 13: 1459-1467 [PMID:36105338] |
glutaminyl-peptide cyclotransferase like/Glutaminyl-peptide cyclotransferase-like protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3638349] [GtoPdb: 3289] [UniProtKB: Q9NXS2] | ||||||||
ChEMBL | Inhibition of recombinant human isoQC using H-Gln-AMC hydrobromide as fluorogenic substrate incubated for 6 hrs by fluorometric microplate reader analysis | B | 6.45 | pIC50 | 351 | nM | IC50 | ACS Med Chem Lett (2022) 13: 1459-1467 [PMID:36105338] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]